Cargando…

Prevalence of Vitiligo among Children and Adolescents in the United States

BACKGROUND: Vitiligo is an autoimmune disorder that causes patchy loss of skin pigmentation. Up to 2.16% of pediatric patients may have vitiligo. This study estimated vitiligo point prevalence in children and adolescents (ages: 4–11 and 12–17 years) in the United States (US). METHODS: An online, pop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Reema, Pandya, Amit G., Sikirica, Vanja, Gandhi, Kavita, Daniel, Shoshana R., Anastassopoulos, Kathryn P., Yamaguchi, Yuji, Napatalung, Lynne, Baik, Rebecca, Ezzedine, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210084/ https://www.ncbi.nlm.nih.gov/pubmed/36630928 http://dx.doi.org/10.1159/000528180

Ejemplares similares

Prevalence of Vitiligo Among Adults in the United States
por: Gandhi, Kavita, et al.
Publicado: (2021)

Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims
por: Ray, Markqayne, et al.
Publicado: (2023)

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis
por: Ezzedine, Khaled, et al.
Publicado: (2023)

Psychosocial Effects of Vitiligo: A Systematic Literature Review
por: Ezzedine, Khaled, et al.
Publicado: (2021)

Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
por: Mostaghimi, Arash, et al.
Publicado: (2021)

Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
por: van Geel, Nanja, et al.
Publicado: (2022)

Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
por: Ray, Markqayne, et al.
Publicado: (2022)

Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA
por: Bibeau, K., et al.
Publicado: (2022)

All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Reliability and validity of the Vitiligo Signs of Activity Score (VSAS)
por: van Geel, N., et al.
Publicado: (2020)

Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
por: Flood, Emuella, et al.
Publicado: (2016)

Clinical and Healthcare Resource Use Outcomes between Dual-plane and Prepectoral Techniques in Implant-based Breast Reconstruction: A Multicenter Retrospective Study
por: Bruno, James R., et al.
Publicado: (2023)

Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
por: Sikirica, Vanja, et al.
Publicado: (2017)

Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder
por: Gajria, Kavita, et al.
Publicado: (2015)

Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study
por: Post, Nicoline F., et al.
Publicado: (2023)

Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013)

Overview of alopecia areata for managed care and payer stakeholders in the United States
por: King, Brett, et al.
Publicado: (2023)

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
por: Fridman, Moshe, et al.
Publicado: (2017)

Common variants in FOXP1 are associated with generalized vitiligo
por: Jin, Ying, et al.
Publicado: (2010)

Clinical epidemiological profile of vitiligo in children and adolescents
por: Marinho, Flauberto de Sousa, et al.
Publicado: (2013)

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria, Kavita, et al.
Publicado: (2014)

Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
por: Campos‐Alberto, Eduardo, et al.
Publicado: (2022)

Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression
por: Jin, Ying, et al.
Publicado: (2019)

Chemical Vitiligo: A Subset of Vitiligo
por: Ghosh, Sanjay
Publicado: (2020)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD
por: Coghill, David R., et al.
Publicado: (2017)

Single-Hair Follicular Unit Transplant for Stable Vitiligo
por: Kumaresan, Muthuvel
Publicado: (2011)

Follicular Unit Extraction as a Therapeutic Option for Vitiligo
por: Sacchidanand, S, et al.
Publicado: (2013)

Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
por: Greven, Peter, et al.
Publicado: (2016)

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
por: Fridman, Moshe, et al.
Publicado: (2017)

Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study
por: Bibeau, Kristen, et al.
Publicado: (2023)

Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
por: Lachaine, Jean, et al.
Publicado: (2016)

Vitiligo /
por: Valderrabano Guitian, Agustín
Publicado: (1987)

Vulvar lesion mimicking vitiligo: A case report
por: Gutierrez, Paula, et al.
Publicado: (2020)

A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
por: Benigno, Michael, et al.
Publicado: (2020)

Economic Study on the Impact of Side Effects in Patients Taking Oxycodone Controlled-Release for Noncancer Pain
por: Anastassopoulos, Kathryn P., et al.
Publicado: (2012)

Impact of Atopic Dermatitis in Adolescents and their Parents: A French Study
por: EZZEDINE, Khaled, et al.
Publicado: (2020)

Real-World Treatment Patterns in Patients with Vitiligo in the United States
por: Rosmarin, David, et al.
Publicado: (2023)

A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures
por: Kitchen, Helen, et al.
Publicado: (2022)

Profile of Vitiligo in Kumaun Region of Uttarakhand, India
por: Agarwal, Saurabh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hh2nl9essqbf1u66bjakl01g2g